The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a $109,725.00 firm fixed price purchase order contract to Bruker Cellular Analysis, Inc. for the BEACON ESSENTIAL SERVICE PLAN. Bruker Cellular Analysis, Inc. is a small disadvantaged business that manufactures optofluidic platforms and consumables for single cell analysis. This award, which has a completion date of June 29, 2025, is likely part of...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Bruker Cellular Analysis, Inc., a self-certified small disadvantaged business and manufacturer of goods, for an optofluidic platform and related consumables. The $219,426.90 contract is to provide an essential service agreement for the NIAID Beacon Optofluidic System, which is utilized by the NIAID's Laboratory...
This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Bruker Cellular Analysis, Inc., a small disadvantaged business manufacturer, for consumables compatible with the Beacon Optofluidic System. The contract has a total ceiling value of $88,292.85 and a period of performance ending on July 30, 2023. The contract was awarded on August 30, 2022 on an other than...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, awarded a $14,654 firm fixed price purchase order contract to Bruker Cellular Analysis, Inc. for the delivery of OPTOSELECT CHIPS. Bruker Cellular Analysis is a small disadvantaged business that manufactures optofluidic platforms and related consumables for single cell analysis. This award supports NIAID's efforts to combat the COVID-19 pandemic, with the chips being...
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $110,000.00 firm fixed price purchase order to Bruker Cellular Analysis, Inc. for an annual maintenance and service plan for the NIAID's Beacon optofluidic system. This system is a critical tool used by NIAID's Antibody Biology Unit to support COVID-19 research and the identification of monoclonal antibodies against SARS-CoV-2. The award was made on a sole source basis under the...
Bruker Cellular Analysis, Inc. was awarded a $367,763 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide optofluidic platform consumables for antibody discovery in support of COVID-19 response efforts. As part of its mission to accelerate and expand biomedical research on infectious diseases, the NIH-NIAID is utilizing Bruker's single-cell analysis technology and consumables to facilitate rapid antibody...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $1.5 million firm fixed-price purchase order to Bruker Cellular Analysis, Inc. to deliver an optofluidic platform for antibody discovery in support of COVID-19 response efforts. As a division of Bruker Cellular Analysis, Inc. located in Oakland, California, the prime contractor will provide the requested products and services from its place of performance in Oakland. The contract supports...
This federal contract award to Bruker Cellular Analysis, Inc. for $331,949.00 was issued by the Department of Health and Human Services' National Institutes of Health, specifically the National Institute of Allergy and Infectious Diseases. The contract is for the provision of an optofluidic platform and related consumables to enable single cell analysis, which is being utilized for antibody discovery and development against SARS-CoV-2 in response to the COVID-19 pandemic. The contract is a...
This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Bruker Cellular Analysis, Inc. for the provision of consumable lab supplies, specifically Optoselect 11k and 20k chips. The contract, valued at $14,654.00, will run through October 31, 2024. Bruker Cellular Analysis, Inc. is a small disadvantaged business that manufactures the optofluidic platforms and related...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, awarded a $1,297,346.54 firm fixed-price purchase order to Bruker Scientific LLC for the delivery of a Bruker Daltonics mass spectrometer model timsTOF flex, including installation, licenses, and operator training. This award is not associated with a set-aside designation. The equipment is intended to support critical analytical work for NIAID's Vaccine Production...